Prognostic Value of Percentage of Positive to Total Excised Axillary Lymph Nodes in Egypt with Triple Negative Breast Cancer: Multiple-Centers Experience

Authors

  • Ahmed Raafat Surgery department, Faculty of Medicine, Zagazig University Hospitals. Zagazig, Egypt.
  • Mansour M Morsy Surgery department, Faculty of Medicine, Zagazig University Hospitals. Zagazig, Egypt.
  • Abd el Motaleb Mohamed Surgery department, Faculty of Medicine, Zagazig University Hospitals. Zagazig, Egypt.
  • Alaa Fayed Surgery department, Faculty of Medicine, Zagazig University Hospitals. Zagazig, Egypt.
  • Mohamed Farouk Amin Surgery department, Faculty of Medicine, Zagazig University Hospitals. Zagazig, Egypt.

Abstract

Background: The total number of axillary lymph nodes [LNs] is the most important prognostic factor in breast cancer. Over long times, different studies indicated that the lymph node ratio [LNR] might predict outcome better than the number of positive LNs. The aim of this retrospective study was to evaluate prognostic value of the lymph node ratio [LNR] in triple negative breast cancer [TNBC]. Materials and Methods: sixety patients with triple negative breast cancer [TNBC] at Zagazig University Hospitals and Fakous Cancer Center were included. We analyzed the impact lymph node ratio [LNR] on the disease free survival [DFS] and overall survival [OS] [calculated by Kaplan–Meier method]. Results: our results showed that the optimal cut off value of LNR value was 0.65, and the optimal cut off value of PLN. The Kaplan–Meier survival analysis showed the higher value of Mean disease free survival among all patients was 33.21 months and 3 year DFS was 50.6%. Disease free survival was significantly longer in those with LNR ≤ 0.65 than those with LNR > 0.65 [Mean: 33.34 months versus 27.46 months; 3year DFS 56.4% versus 36.9% respectively]. Mean overall survival among all patients was 36.90 months and 3 year OS was 50.4%. Overall survival was significantly longer in those with LNR ≤ 0.65 than those with LNR > 0.65 [Mean: 39.40 months versus 29.63 months; 3 year OS 73.8% versus 23.3% respectively]. Conclusion: These results suggest that TNBC patients with lower value of LNR good prognosis than with high LNR patients. The LNR is an independent prognostic factor, thus, LNR may be added to the current staging system. Key Words: Triple-negative Breast cancer [TNBC], Lymph node ratio, Axillary lymph node,

Downloads

Download data is not yet available.

Additional Files

Published

2018-09-19

How to Cite

Ahmed Raafat, Mansour M Morsy, Abd el Motaleb Mohamed, Alaa Fayed, & Mohamed Farouk Amin. (2018). Prognostic Value of Percentage of Positive to Total Excised Axillary Lymph Nodes in Egypt with Triple Negative Breast Cancer: Multiple-Centers Experience. International Journal of Life Sciences, 6(3), 719–732. Retrieved from https://ijlsci.in/ls/index.php/home/article/view/153

Issue

Vol. 6 No. 3 (2018): International Journal of Life Sciences

Section

Research Articles

License

Copyright (c) 2018 Ahmed Raafat, Mansour M Morsy, Abd el Motaleb Mohamed, Alaa Fayed, Mohamed Farouk Amin

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license unless indicated otherwise in a credit line to the material. If the material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/ licenses/by/4.0/